Literature DB >> 26232476

Inflammation in chronic thromboembolic pulmonary hypertension: accomplice or bystander in altered angiogenesis?

Paul M Hassoun1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26232476     DOI： 10.1183/13993003.00962-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  5 in total

1.  Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.

Authors:  Shuxin Liang; Ankit A Desai; Stephen M Black; Haiyang Tang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Evaluation of the hemodynamics and right ventricular function in pulmonary hypertension by echocardiography compared with right-sided heart catheterization.

Authors:  Yidan Li; Yidan Wang; Hong Li; Weiwei Zhu; Xiangli Meng; Xiuzhang Lu
Journal:  Exp Ther Med       Date:  2017-08-17       Impact factor: 2.447

Review 3.  Epigenetic Targets for Oligonucleotide Therapies of Pulmonary Arterial Hypertension.

Authors:  William Gerthoffer
Journal:  Int J Mol Sci       Date:  2020-12-03       Impact factor: 5.923

Review 4.  Chronic Thromboembolic Pulmonary Hypertension: An Update.

Authors:  Barbara Ruaro; Elisa Baratella; Gaetano Caforio; Paola Confalonieri; Barbara Wade; Cristina Marrocchio; Pietro Geri; Riccardo Pozzan; Alessia Giovanna Andrisano; Maria Assunta Cova; Maurizio Cortale; Marco Confalonieri; Francesco Salton
Journal:  Diagnostics (Basel)       Date:  2022-01-19

5.  Chronic Thromboembolic Pulmonary Hypertension: An Observational Study.

Authors:  Barbara Ruaro; Paola Confalonieri; Gaetano Caforio; Elisa Baratella; Riccardo Pozzan; Stefano Tavano; Chiara Bozzi; Selene Lerda; Pietro Geri; Marco Biolo; Maurizio Cortale; Marco Confalonieri; Francesco Salton
Journal:  Medicina (Kaunas)       Date:  2022-08-13       Impact factor: 2.948
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.